Back to ARROWSTREET CAPITAL, LIMITED PARTNERSHIP ARROWSTREET CAPITAL, LIMITED PARTNERSHIP

TBPHTBPH
5 quarters

Position history for ARROWSTREET CAPITAL, LIMITED PARTNERSHIPARROWSTREET CAPITAL, LIMITED PARTNERSHIP's holdings in THERAVANCE BIOPHARMA INC

ARROWSTREET CAPITAL, LIMITED PARTNERSHIP holds 327,546 shares of TBPH (THERAVANCE BIOPHARMA INC), worth $5.3M as of 2026-Q1. The position was decreased (-66.0% shares). TBPH represents 0.0% of ARROWSTREET CAPITAL, LIMITED PARTNERSHIP's portfolio.

Current Value

$5.3M

Current Shares

327,546

Total Value Change

+$3.3M

Total Shares Change

+106,077

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Decreased
327,546
-66.0%
$5.3M0.0%$13.96
0
2025-Q4
Increased
963,257
+32.5%
$18M0.0%$18.91
36
2025-Q3
New
726,783
-
$10.6M0.0%$14.43
38
2025-Q2
Exited
0
-100.0%
$00.0%$11.22
0
2025-Q1
New
221,469
-
$2M0.0%$9.23
36

Other major holders of TBPH: BAUPOST GROUP LLC/MA

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used